Please provide your email address to receive an email when new articles are posted on . Substantial differences in arteriovenous fistula maturation were seen across some end-stage renal disease ...

Please provide your email address to receive an email when new articles are posted on . “If there is a clinical concern about [arteriovenous fistula] AVF maturation after surgery, a 6-week ultrasound ...

More than a third of patients required interventions to foster AVF maturation. Intervention is commonly required to foster maturation of arteriovenous fistulas (AVFs), maintain patency, and treat ...

This requires durable access to a blood vessel site where the dialysis machine can remove and return blood. Such access is created when a surgeon attaches a vein to an artery in the patient. The ...

An investigational product called Acellular Tissue Engineered Vessel demonstrated superior hemodialysis vascular access outcomes compared with AVFs in a phase 3 trial. A bioengineered human tissue ...

April 2, 2009 (Nashville, Tennessee) — Evaluation of blood flow soon after creation of an arteriovenous fistula (AVF) can differentiate those that will mature into suitable and those that will mature ...

Timmy Lee, MD, MSPH, is Associate Professor of Medicine in the Division of Nephrology and Staff Nephrologist at the Birmingham Veterans Affairs Medical Center. He is the Associate Director of ...

SALT LAKE CITY--(BUSINESS WIRE)--Alucent Biomedical Inc., a company dedicated to developing and commercializing its breakthrough AlucentNVS technology for the treatment of vascular disease, announced ...

BIRMINGHAM, Ala. – More than 600,000 people in the United States have end-stage kidney disease, and about 450,000 are kept alive through chronic hemodialysis to remove waste products from their blood.